Evidence map›Paper›PMID 23996104›Full record

ArticleInflammation2014

Seminal levels of IL-10, IL-12, and IL-17 in men with asymptomatic chlamydia infection.

Hamid Hakimi, Mohammad Mehdi Akhondi, Mohammad Reza Sadeghi, Leila Chamani, Mohammad Kazemi Arababadi, Behzad Nasiri Ahmadabadi, Gholamhossein Hassanshahi, Mahmoud Sheikh Fathollahi

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. UnveilingiScience · 2025
    Article
  2. Reduction ofVaccine: X · 2023
    Article
  3. Insights Into Host Cell Cytokines inFrontiers in immunology · 2021
    Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hamid HakimiImmunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Mohammad Mehdi Akhondi
Mohammad Reza Sadeghi
Leila Chamani
Mohammad Kazemi Arababadi
Behzad Nasiri Ahmadabadi
Gholamhossein Hassanshahi
Mahmoud Sheikh Fathollahi
Rafsanjan University of Medical Sciences · IRShahid Beheshti University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlamydia trachomatis, as an obligate intracellular parasite, usually causes asymptomatic genital tract infections in both men and women with several complications. The role of C. trachomatis infection in the secretion of a number of interleukins (ILs) from epithelial cells has been established by in vitro studies performed on various cell lines. The aim of this study was to detect the seminal levels of IL-10, IL-12, and IL-17 in men with asymptomatic chlamydia infection. Our case group study included 50 semen samples being PCR-positive for C. trachomatis from 585 semen samples and the ELISA method was applied for detection of IL-10, IL-12, and IL-17. Our results demonstrated that the semen levels of IL-10 and IL-17 were significantly increased, while IL-12 was decreased in C. trachomatis-infected patients. According to these results, it may be concluded that the increased and decreased semen levels of IL-10 and IL-12, respectively, lead to impaired immune responses against C. trachomatis. Increased semen levels of IL-17 may also be associated with the pathogenesis of C. trachomatis infection.

Indexed as

Asymptomatic InfectionsChlamydia InfectionsChlamydia trachomatisHumansInterleukin-10Interleukin-12Interleukin-17MaleReproductive Tract InfectionsSemenIL10 protein, humanInterleukin-10Interleukin-12Interleukin-17

Identifiers

PMID23996104
OpenAlexW2008915850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.